Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumors

The intent of this study was to evaluate the safety and efficacy of high-activity 111In-pentetreotide in patients with neuroendocrine tumors. Thirty-two patients with pentetreotide-avid neuroendocrine tumors received therapy from August 2005 to November 2006. Fourteen (14) patients received 1 treatm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer biotherapy & radiopharmaceuticals 2008-06, Vol.23 (3), p.292-300
Hauptverfasser:	Delpassand, Ebrahim S, Sims-Mourtada, Jennifer, Saso, Hitomi, Azhdarinia, Ali, Ashoori, Faramarz, Torabi, Farzad, Espenan, Gregory, Moore, Warren H, Woltering, Eugene, Anthony, Lowell
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Female Humans Indium Radioisotopes - therapeutic use Male Maximum Tolerated Dose Middle Aged Neuroendocrine Tumors - radiotherapy Regression Analysis Somatostatin - analogs & derivatives Somatostatin - therapeutic use Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!